A patient is treated chronically with a drug (A) metabolized by CYP 3A4. Recently he administer another drug (B) which is an enzymatic inducer of the CYP2D6. Which of the following is likely to occur?
A) Longer half life of drug (A)
B) Longer half life of drug (B)
C) Enhanced pharmacological effect of drug A
D) No significant drug interaction
E) Reduced pharmacological effect of drug B
Correct Answer:
Verified
Q58: Principal organ/s for biotransformation of drugs is/are
A)
Q59: Advantages of the rectal route of drug
Q60: Binding of a drug to plasma proteins
Q61: Compared to the average adult dose, the
Q62: Which one of the following statements is
Q64: In general, biotransformation usually results in a
Q65: Enzyme inhibitors such as Cimetidine and Erythromycin
Q66: What does "affinity" mean?
A) A measure of
Q67: Target proteins, which a drug molecule could
Q68: An agonist is a substance that ?
A)
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents